TY - CONF A1 - Schneider, Rudolf T1 - Enhancing wastewater surveillance through anthropogenic markers N2 - Since the global COVID-19 pandemic, there has been an increased focus on systematically monitoring pathogens in raw wastewater - a practice known as wastewater-based epidemiology (WBE). This approach, aligned with the One Health concept, the revised EU Urban Wastewater Treatment Directive (2024), and Germany’s amended Infection Protection Act (2023), aims to generate health data independently of individual testing and reporting behaviors through wastewater surveillance. – Germany’s AMELAG project implemented wastewater surveillance at approximately 170 treatment plants, with biweekly sampling. This infrastructure - comprising treatment plants, logistics, laboratories, and health authorities - also provided us samples that were analyzed for their levels of a series of anthropogenic markers. These markers improve data accuracy by accounting for site-specific variations in wastewater composition and flow rates, such as those caused by stormwater runoff. Beyond epidemiology, wastewater surveillance provides valuable insights into the spread of antimicrobial resistance (AMR), drug consumption, industrial discharges, and the efficiency of wastewater treatment plants in eliminating indicator substances. To assess these factors, cost-effective, high-throughput methods such as ELISA (Enzyme-Linked Immunosorbent Assay) offer a practical solution. This study examines ELISA’s application in detecting diclofenac, carbamazepine, and bisphenol A in wastewater samples from various locations. T2 - Pacifichem 2025 CY - Honolulu, HI, USA DA - 15.12.2025 KW - Antibodies KW - Immunoassay KW - Pharmaceuticals PY - 2025 AN - OPUS4-65720 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Schneider, Rudolf T1 - Advancing environmental screening and monitoring: Immunoanalytical approaches for emerging contaminants N2 - Micropollutants, including various emerging contaminants, are continuously released into the environment. Detecting their presence using conventional analytical methods is often expensive and time-consuming, making large-scale monitoring impractical. To effectively protect ecosystems and human health, rapid and cost-efficient screening methods are essential. Furthermore, the need to monitor the entire water cycle for micropollutants is becoming increasingly critical, particularly from a One Health perspective, as climate change and growing demands for water reuse amplify environmental challenges. – Antibody-based methods, commonly referred to as immunoassays, offer a promising solution. These rapid and cost-effective techniques can fill information gaps and provide sensors and process analytical technology with short response times. A wide range of immunoanalytical formats is available, from laboratory-based methods to portable analyzers and online sensors. Ensuring the availability of high-quality antibodies is essential to the reliability of these approaches. This talk presents how a whole range of immunoanalytical methods can be employed to trace emerging contaminants in the environment. An indicator for specific industrial inputs is bisphenol A which is also an endocrine disruptor. Additionally, pharmaceuticals serve as important markers of human impact on the water cycle. Natural tracers, such as endogenous hormones and bile acids, help track wastewater pathways, while anthropogenic markers - most notably caffeine - serve as indicators of human activity, frequently appearing in environmental water samples. T2 - Pacifichem 2025 CY - Honolulu, HI, USA DA - 15.12.2025 KW - Antibodies KW - Immunoassay KW - Pharmaceuticals PY - 2025 AN - OPUS4-65719 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Devi, Sarita A1 - Goel, S. A1 - Rani, S. A1 - Schneider, Rudolf J. A1 - Rohilla, R. A1 - Kumari, Surbhi A1 - Prabhakar, N. T1 - MOF-metal nanohybrid-assisted charge transfer amplification for electrochemical biosensing of the MUC1 cancer biomarker N2 - Cancer is a severe disease characterized by high mortality and complex pathophysiology; however, its early and accurate diagnosis remains inadequate. Conventional diagnostic approaches often fall short, particularly for dense tissues, and are frequently invasive, costly, and of limited availability. This reinforces the need for a compact, economical, and ultrasensitive assay that is operationally simple and interpretable. We present an efficient electrochemical detection platform for the cancer biomarker mucin 1 (MUC1). A fluorine-doped tin oxide (FTO) surface was modified with an iron-based metal–organic framework (FeMOF) intercalated with palladium nanorods (PdNR). FeMOF was prepared using Fe3+/Fe2+ precursors at a 1.2/1 mmol ratio and dual ligands, i.e. tetrahydroxy-1,4-benzoquinone and 2-aminobenzene-1,4-dicarboxylic acid. AntiMUC1 antibodies were immobilized on a modified electrode via p-phenylenediamine (PDA) (FTO/FeMOF@PdNR/PDA/antiMUC1Ab) and evaluated using electrochemical impedance spectroscopy (EIS) and voltammetry. The designed sensor demonstrated an excellent binding affinity for the MUC1 antigen. Among these techniques, the EIS method stands out for its technical performance, as evidenced by the high sensitivity (detection limit 0.074 fg mL−1), quantification limit 0.24 fg mL−1, and high analytical sensitivity (1.39 × 103 Ω fg−1 mL−1 cm−2). The negligible cross-reactivity with interferent biomolecules, rapid response (10-minute equilibrium), regenerability up to 5 cycles, high reproducibility (RSD ∼1–3%), and long-term stability (up to 35 days) further validate the suitability of the proposed MUC1 immunosensor. This study presents an ultrasensitive biosensor that is compact, cost-effective, and easy for individuals at home to use after further development into a kit-based end product. Moreover, its excellent functionality for spiked serum samples shows promise for next-generation clinical diagnostics. KW - Antibodies KW - Metal-organic framework KW - Immunoassay PY - 2026 DO - https://doi.org/10.1039/D6AN00018E SP - 1 EP - 11 PB - Royal Society of Chemistry CY - London AN - OPUS4-65726 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -